Bortesoh
Bortesoh 3.5mg Lyophilized Powder for Injection
Bortezomib
Drug Identity
Active Ingredient
Bortezomib
What is Bortesoh?
Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...
How to Take It
Dosage information not available for this product.
Safety Alerts
Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed
Important Warnings
Monjuvi may cause the following serious side effects: Infusion reactions
Your healthcare provider will monitor you for infusion reactions during your infusion of Monjuvi
Tell your healthcare provider right away if you get a fever, chills, rash, flushing, headache, or shortness of breath during an infusion of Monjuvi
Low blood cell counts (platelets, red blood cells, and white blood cells)
Low blood cell counts are common with Monjuvi, but can also be serious or severe
Your healthcare provider will monitor your blood counts during treatment with Monjuvi
Tell your healthcare provider right away if you get a fever of 100
4°F (38°C) or above, or any bruising or bleeding, or fever, mouth sores, skin sores, sore throat , cough, trouble breathing
Side Effects
The most common side effects of Monjuvi when given with lenalidomide in DLBCL are: respiratory tract infection feeling tired or weak diarrhea cough fever swelling of the lower legs or hands decreased appetite infusion-related reactions. The most common side effects of Monjuvi when given with lenalidomide and rituximab in FL are: respiratory tract infections diarrhea rash feeling tired or weak muscle and bone pain constipation cough infusion-related reactions.
Drug Interactions
Other drugs may interact with Monjuvi
including prescription and over-the-counter medicines
vitamins
and herbal products . Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements.
Price Intelligence
Rs 52,503.1
DRAP approved maximum price · per unit · approved 19 Aug, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper unitRs 52,503.1
Should you consider an alternative?
Other options containing Bortezomib, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Alvocadesingleusevialpowderfor
3.5mg
Rs 35,447.02
No DRAP alertsGene-Tech Laboratories DSL: 0311
Pfizerpakistanltdbortezomib
3.5mg
Rs 36,773.62
No DRAP alertsPfizer Pakistan Limited DSL: 687
Bortezomib
3.5mg
Rs 45,241.34
No DRAP alertsHimmel Pharmaceuticals Private Limited DSL: 05-352-0065-016174D
Mprib
3.5mg
Rs 56,216.82
No DRAP alertsLab Diagnostic Systems (SMC) Pvt. Ltd. DSL: 01-374-0006-118530D
Cytomib
3.5mg
Rs 48,623.87 ceiling
Helix Pharma (Pvt)., Ltd.
Fonkozomib
3.5mg
Rs 37,198.1 ceiling
No DRAP alertsAmgomed
Protezomib
3.5mg
Rs 37,928.31 ceiling
No DRAP alertsAJM Pharma Pvt Ltd
Bortezomib Pharmidea
3.5mg
Rs 45,241.34 ceiling
No DRAP alertsHimmel Pharmaceuticals Private Limited
Veltezo
3.5mg
Rs 59,725.53 ceiling
No DRAP alertsMartin Dow Limited
Bortoma
3.5mg
Rs 53,554.97 ceiling
No DRAP alertsHakimsons (Pvt)., Ltd.
Revibort
3.5mg
Rs 53,553.38 ceiling
No DRAP alertsREVIVE HEALTH CARE
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
18
brands
31
molecules
0
alerts